The intersection of reproductive endocrinology & women's health with diabetes presents unique challenges across different life stages. Polycystic ovary syndrome (PCOS) and gestational diabetes mellitus (GDM) are common metabolic disorders linked to insulin resistance, affecting fertility and pregnancy outcomes. Hormonal fluctuations influence glycemic control, making diabetes management more complex during puberty, pregnancy, and menopause. Emerging research highlights the impact of sex hormones on glucose metabolism and the role of individualized treatment approaches in optimizing reproductive health. Advancements in assisted reproductive technologies, targeted hormonal therapies, and lifestyle interventions improve fertility outcomes and maternal health. A comprehensive approach integrating endocrinology, obstetrics, and metabolic management is essential for addressing these challenges effectively.
Title : Adipose MTP deficiency protects against hepatic steatosis by upregulating PPAR activity
Sujith Rajan, NYU Long Island School of Medicine, United States
Title : Important roles and mechanisms of novel calcium signaling in diabetes-induced vascular dementia
Yong Xiao Wang, Albany Medical College, United States
Title : Does winter melon (Benincasa hispida) improves nutritional values and ameliorating glycaemic parameters ?
Wan Rosli Wan Ishak, Universiti Sains Malaysia, Malaysia
Title : The menopausal mind: Reframing female senescence as a neuroendocrine disorder with root cause management strategies
Amy Gutman, AdventHealth; Tough Love MD, United States
Title : Diabetes reduction (pre-diabetes and type 2) with integrative medicine
F Buck Willis, University of Belize, Belize
Title : Serum fructosamine: A more accurate screening test than 3-hour OGTT for diagnosis of gestational diabetes
Sarah Exley, Broadlawns Medical Center, United States